Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

D. Adachi, Jonathan; Bensen, W.; P. Brown, Jacques; A. Hanley, David; B. Hodsman, Anthony; G. Josse, Robert; L. Kendler, David; C. Lentle, Brian; P. Olszynski, Wojciech; Ste.-Marie, Louis-George; Tenenhouse, Alan; Chines, Arkadi; Jovaisas, A.; C. Sturtridge, W.; Anastassiades, Tassos; G. Hanly, John; Pope, Janet; Dias, Reginald; D. Horowitz, Zebulun; Pack, Simon

doi:10.1056/nejm199708073370603

Public

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

Published in New England Journal of Medicine • Aug 7, 1997

Authors:

Jonathan D. Adachi

W. Bensen

Jacques P. Brown

Abstract

BACKGROUND AND METHODS: Osteoporosis is a recognized complication of corticosteroid therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, placebo-controlled study of intermittent etidronate (400 mg per day for 14 days) followed by calcium (500 mg per day for 76 days...

Subject

Medicine

Trochanter

Femoral neck

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!